First principles quantum mechanical calculations with methods such as density functional theory (DFT) allow the accurate calculation of interaction energies between molecules. These interaction energies can be dissected into chemically relevant components such as electrostatics, polarisation and charge transfer using energy decomposition analysis (EDA) approaches.
Introduction
The ability to understand the driving forces of molecular interactions is a key goal towards solving many important problems of chemistry, for example in the development of new materials such as catalysts [1] [2] [3] and polymers, [4] [5] [6] [7] [8] and the fine tuning of drug-biomolecule interactions. [9] [10] [11] Determination of these driving forces is not trivial, with many different effects combining to produce an overall interaction energy. Energy decomposition analysis (EDA) refers to the number of approaches 12 that have been developed to aid our understanding of these forces. These methods separate the interaction energy (∆E) into a series of chemically intuitive energy terms. Many such methods have been proposed in the literature, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] typically partitioning ∆E into electrostatics, exchange, correlation, Pauli-repulsions, polarisation, charge transfer and dispersion terms, and combinations of these.
Many popular variational-based EDA methods have been developed from the pioneering KitauraMorokuma (KM) scheme. 13, 25, 26 An example of one such scheme is the absolutely localised molecular orbital (ALMO) EDA scheme, 20, 27, 28 closely related to the block-localised wavefunction (BLW) EDA, [29] [30] [31] that seeks to decompose the interaction energy into frozen density, polarisation and charge transfer energy terms. More recently, alternative treatments for polarisation have been proposed such as the EDA of Wu 22, 32 and the approach of Horn and Head-Gordon. 33 We have published a review 12 comparing the different EDA approaches within the scope of drug design which may be of interest to the inquisitive reader.
Despite the extensive progress in the development of EDA methods, there have been so far few attempts to use them in drug design applications. Examples of such work include the application of the pair interaction EDA 34 (PIEDA) by Heifetz et al. to study the binding of inhibitors to interleukin-2 inducible T-cell kinase, 35 the orexin-2 receptor 36 and other G-protein-coupled receptors, 37 and the application of the KM and natural 16, 17 EDA approaches to study the binding of Cl-ions in the Cl-/H+ exchange transporter protein by Church et al. 38 Here, polarisation and charge transfer were found to play important roles in these binding interactions. Recently, Fedorov and Kitaura 39 EDA has the exciting potential to guide the pharmaceutical modification of drug-protein interactions in systems many thousands of atoms in size. We have recently presented in literature 21 an EDA method developed in the ONETEP DFT package capable of such large-scale analyses.
Towards this goal we have sought to study with EDA the thrombin protein which contains an active site consisting of three well-shaped pockets: S1, S2, and S3/4. 40 This a serine protease that plays a central role in the blood coagulation cascade, in which insoluble fibrin is formed by the action of thrombin on fibrinogen. 40, 41 The delay of coagulation by direct inhibition of thrombin is therefore a key target for the treatment of thrombosis, for example by interaction of the drug molecules ximelagatran or dabigatran. 42 In this paper, we investigate the interactions of thrombin in two cases. These two cases have separate objectives, but share an overall aim of exploring the usefulness of large-scale EDA with ONETEP for drug design. In the first case, we apply the ONETEP EDA to small, structurally comparable fragments interacting with the thrombin protein S1 pocket. Here, our aim is to demonstrate the practical use of our EDA for rationalising the energetics observed and identifying the key functional groups involved in drug-ligand binding.
In the second case, we consider the interactions of larger thrombin drug binders partitioned into fragments. Our motivation is to assess the performance of the EDA for investigating the energetic contributions of specific functional motifs to binding and also investigate the level at which ligand fragmentation can have additive interactions.
Theory
We have implemented within the ONETEP 43 package a combination of the ALMO EDA approach 20 and the frozen density component analysis based upon the LMO EDA approach. 19 This development has been described in detail in earlier published literature. 21 In this section, we provide a brief overview of this EDA method and a trivial extension for solvation that is used within the studies of this work.
The ONETEP EDA
The original ONETEP EDA approach 21 decomposes the (gas phase) interaction energy ∆E vac into electrostatic (∆E ES ), exchange (∆E EX ), Pauli-repulsion (∆E REP ), correlation (∆E CORR ), polarisation (∆E POL ) and charge transfer (∆E CT ) energy components as
The frozen density component (∆E FRZ ) that represents the interaction of the frozen, unperturbed charge densities of the monomers is the total of the electrostatic, exchange, Pauli-repulsion, and correlation terms, i.e.
By substitution of Eq. 2 into Eq. 1, the decomposition may be expressed in compact form as
similar to that of the original ALMO EDA scheme. 20 
Solvation
The EDA scheme described above is trivially extended to account for solvation effects during binding. This component is included as a correction to ∆E vac , and its inclusion does not affect the original energy component definitions described in Eq. 1.
The solvent interaction correction to ∆E vac , ∆E SOLV , is given by
where E sol is the total energy calculated using the ONETEP solvation model 44 which is a selfconsistent model based on direct solution of the non-homogeneous Poisson equation. The calculation of the solvation contribution is shown diagrammatically in Figure 1 .
The overall solvation corrected interaction energy decomposition is given by
We should note that the definition of the interaction energy in Eq. 5 describes a portion of the enthalpy (∆H) component of the Gibbs' free energy of binding (∆G). Some of the remaining enthalpic portion may be included as additional energy components to the EDA. For example, in ligand-protein binding the interaction energy may be augmented to include the dispersion energy of the ligand leaving the solvent using an empirical-based approach. Additionally, strain effects may be taken into account by relaxation of the molecules in isolation. A comparison of the binding enthalpies (calculated by inclusion of these effects) for the ligands studied in this work with Figure 1 : Calculation of the solvation contribution to ∆E for a model protein -ligand system. Energies of the protein (P) and ligand (L) calculated in solvent are represented using a blue box. The total (gas phase) interaction energy described in the original EDA (Eq. 1) is given by the energy change of the process (B). The correction for solvation, ∆E SOLV , is given by the total energy change of the process
experimental thermodynamic parameters is provided in the Supporting Information (Supporting Information Available).
Electron density differences
Whilst the EDA provides energetic quantities useful for understanding the overall driving forces of binding, these do not provide any insight into the spatial regions of importance to binding. Notably, the energies provided by the EDA do not provide information of the key functional groups that contribute to binding through effects such as polarisation and charge transfer. This information would be highly valuable from a drug-design perspective, as this provides insight into regions of ligands relevant for structural modification.
As part of the ONETEP EDA approach, electron density difference (EDD) plots are computed that provide ready access to this valuable information. These plots that indicate the significant electron density redistributions that occur during polarisation and charge transfer are calculated as
where n FRZ (r), n POL (r), and n 0 (r) are the frozen, 45 polarised, and fully relaxed electron densities respectively. These can be understood by considering the densities used in these computations: the polarisation EDD plot shows the effect of polarising the frozen monomer densities, and the charge transfer EDD plot shows the effect of allowing full electron delocalisation having already polarised the individual monomer charge densities.
EDD plots of geometrically similar ligands may be subtracted 46 from one another to investigate the chemistry of their differing functional groups. In this work, these plots are referred to as ∆EDD plots and are calculated as n ∆EDD(POL) (r) = abs n EDD(POL,X1) (r) − abs n EDD(POL,X2) (r) (7a)
where X1 and X2 refer to the two ligands being analysed using ∆EDD plots, with positive iso- 
Calculation details
The ability to observe differences in structural features of ligands is of key importance within this work. For this reason, thrombin fragments and ligands were taken from the literature of Rühmann et al. 40 and Baum et al. 47 based on their high suitability for structural comparison (i.e. the ligands are structurally different, but not so dissimilar as to prevent comparison). The PDB codes of the structures selected for the S1 pocket analysis were 5AHG, 40 5AFY, 40 4UD9, 40 5AF9, 40 4UEH, 40 and 4UE7, 40 and the PDB codes of the thrombin-ligand complex structures selected for fragmentation studies were 4UDW, 40 2ZGX, 47 and 5AFZ 40 (downloaded from the Protein Data Bank 48 ). In this work, the S1 pocket binders are referred to as L1 to L6 respectively and the thrombin ligands are referred to as L7 to L9. A figure of these ligands superposed in the protein cavity is shown in Figure 2 .
The following protocol was used to prepare the protein structures for EDA. The missing 7-loop (residues Trp147A, Thr147B, Ala147C, Asn147D, Val147E, Gly147F, and Lys147G) of each of the initial thrombin-inhibitor crystal structures was built using MOE homology modelling suite.
Each structure was then capped using COCH 3 and NHCH 3 groups, and protonated using the Protonate3d software. 49 The structures were energy minimised using the MMFF94x forcefield with the generalised Born implicit solvent (GBIS) model using tether restraints with a force constant of (3/2)kT /σ 2 (σ = 0.5Å) for all atoms during the minimisation. Additional calculations have been performed demonstrating the stability of the ONETEP EDA with respect to geometry variations resulting when using different geometry optimisation procedures (Supporting Information Available). The hirudin and all waters (excluding the structural water molecules involved in the Asp189 salt bridge interaction in the L5, L6, L8, and L9 systems) were subsequently removed from the systems. These structures were then truncated to remove residues beyond 15Å of the ligand, and further truncated to ensure consensus of the protein residues across all of the systems. Further capping of the cleaved backbone of the structures was performed using COCH 3 and NHCH 3 groups to leave protein model structures 2740 atoms in size.
The ligands L7, L8, and L9 were further partitioned into fragments that interact with particular regions of the thrombin active site. Specifically, we have selected fragments with index F1 to interact with the S1 pocket, F2 with the S2 pocket, and F3 to interact with the S3/4 pocket. Positions of the ligand fragmentations are shown in Figure 3 . To partition the ligands into fragments, the selected bonds were cleaved and capped with hydrogens.
ONETEP EDA was performed on the resulting thrombin-fragment and thrombin-ligand sys- Figure 2 : Superposition of the geometry optimised fragments and ligands within the thrombin pocket. The protein and water geometry shown is the optimised L8 system with non-contributing distant amino acids hidden for clarity.
tems using a 800 eV psinc basis set cutoff energy and 8.0 Bohr NGWF radii at the PBE level of theory. In this EDA calculation, the structural waters of L5, L6, L8, and L9 were treated as belonging to the thrombin monomer. The solvent correction energies (∆E SOLV ) were calculated at the same level of theory including the ONETEP solvation model. 44 This was performed using a fixed cavity, with a unitless β parameter of To quantify the error introduced through fragmentation of the ligands, an 'additivity' error is defined for each energy component. This quantity is expressed as
where 4 Analysis: S1 pocket ligands
In this section, we analyse the binding of the fragment ligands (L1 to L6) with the thrombin S1 pocket, with specific attention towards use of EDA as a tool for drug design. The structures of these ligands are shown in Figure 4 , and plots of the EDA components are displayed in Figure 7 and a given drug. In the following discussion, we analyse the ligands as pairs in order to demonstrate how EDA can be used to pinpoint the changes in the energy components caused by modifying functional groups, and hence guide fragment based drug design applications.
Ligands L1 and L2
Here we consider the interactions of the structurally comparable L1 and L2 ligands which both share a similar chlorobenzene functional group. These ligands show notable overlap when superposed within the binding pocket and therefore present strong candidates for comparison using EDA.
Although these ligands are conformationally similar, differences are observed in the Ser195
and Glu192 protein residue positions as seen in the EDD and ∆EDD plots of Figure 5 (a)-(c) and
In these plots, we see that the para-and meta-substitution of these ligands results in different interactions with alternate sides of the binding pocket. Specifically, the para-substituted L1 sulfonamide interacts primarily with the Gly219 residue, whereas the meta-substituted L2
amide is observed to interact with the Ser195 residue alone.
We begin by considering the frozen interactions of the L1 and L2 ligands with the thrombin protein. The magnitudes of the individual frozen density interaction components are much larger in the L1 system than the L2 system. Notably, Pauli repulsions are 13.0 kcal/mol more repulsive in the L1 interaction. This is due to the greater size of the L1 ligand than the L2 ligand, despite the close interaction (1.7Å separation) of the L2 ligand with the Ser195 hydrogen. Overall, the stronger interactions seen for L1 balance to give an overall frozen density component of 2.1 kcal/mol which is comparable to that seen in L2 (2.8 kcal/mol).
The EDD and ∆EDD plots connect the EDA energetics with the structural features of ligandprotein interactions. Importantly, these allow us to see the ligand functional groups that are most responsible for the interactions. In the EDD plots, we see polarisation and charge transfer interactions of the L1 sulfamoyl group with Gly219, and the L2 amide group with Ser195. In the ∆EDD plot, we observe clear cancellation of the minor Asp189 residue charge transfer interactions 
Ligands L3 and L2
As in the case of the L1 and L2 ligand pair, the L2 and L3 ligands are structurally compara- However, these ligands' interactions differ significantly through the hydrogen bonds that they form with the protein cavity. The L3 ligand forms three observable hydrogen bonds with the Gly219 and Glu192 residues, whereas L2 forms an observable hydrogen bond with Ser195. These interactions are shown clearly in the EDD and ∆EDD plots of Figure 5 More subtly, the benzene of L2 favours a conformation with two hydrogens interacting with the Asp189 residue, whereas the L3 conformation primarily involves one hydrogen interacting with the Asp189 residue and another with the Cys220 backbone. Overall therefore, these structurally 
Ligands L3 and L4
We now consider the interactions of the L3 and L4 ligands. 
Ligands L5 and L6
Here, we consider the interactions of the two charged ligands of our study, L5 and L6. We begin our discussion by considering the important overall differences between these two ligands' It is also important to note that whilst the EDA results account for the enthalpic stability (∆H) of binding, these values do not account for entropic effects (∆S) involved in quantifying the Gibbs' free energy of binding (∆G = ∆H − T ∆S). For example, the additional rigidity of the L5 ligand compared to L6 may result in the L5 ligand displaying an overall more favourable free energy of binding than L6, despite the greater enthalphic stability in L6. This insight is supported quantitatively by the thermodynamic parameters determined by Rühmann and coworkers. 40 
Analysis: fragmented ligands
In this section, we analyse the binding of the L7, L8, and L9 ligands and their fragments with thrombin (shown in Figure 3) . Plots of the EDA components are displayed in Figure 9 and 
Frozen density component
We begin our discussion by noting the important role of electrostatics, and in particular those arising from the fragment charges, as a factor in determining the overall ∆E. We expect strong electrostatics in the L8 and L9 ligands through interaction of their amidine functional group with the Asp189 amino acid residue. Importantly, by partitioning the ligands into functional group regions, we are able to quantify the contribution of this amidine-Asp189 interaction. For these two ligands, the amidine functional group forms part of the F1 fragment. We observe total electrostatic energy components of −208.3 kcal/mol (L8) and −169.7 kcal/mol (L9) for the full ligand, of which the F1 fragments contribute −129.2 kcal/mol and −135.7 kcal/mol respectively ( Figure 9 ).
From this, we are able to conclude that this salt bridge interaction contributes well over half of the electrostatics in these systems.
Electrostatics are also shown to be important in the charged F3 fragments of L7 and L8. We expect that strong stabilising contributions arise through interaction of the charged amine group with the Gly216 oxygen as shown in Figure 11 (a)-(c) and Figure 12 (a)-(c). The electrostatic stability provided by these fragments is −71.2 kcal/mol (L7) and −59.3 kcal (L8), with greater stability seen in the L7 ligand due to the presence of benzene in this fragment (see Figure 3) . The benzene group of L7 may enhance electrostatics above L8 through inductive effects stabilising the amine charge. Understanding effects such as this is important to developing knowledge of the subtle forces that enhance drug-protein binding, demonstrating the high value of the EDA.
Whilst the ability to extract functional group energetics from the EDA is a powerful ability, it is important to consider the error that may be introduced by the bond partitioning process. Notably, we observe a 6.5 kcal/mol difference in electrostatics for the F1 fragments of the L8 and L9 systems despite these fragments sharing identical chemical structures. Errors in the electrostatic component due to fragmentation (calculated using Eq. 8) are < 1 kcal/mol and therefore bond partitioning itself is unlikely to be the origin of this difference. For this reason we conclude that this difference most likely arises from variances in the structural geometries. This observation demonstrates that care must be taken drawing conclusions from EDA results using a single structure, and it is expected Energy components of E (kcal/mol)
F2 F3 Error Figure 10 : EDA components of the fragmented L7, L8, and L9 ligand interactions calculated at the PBE/800 eV level of theory. F1, F2, and F3 refer to the fragments that compose the full ligand. For each energy component, the fragmentation error equals the sum of the fragment contributions subtracted from the contribution of the full ligand (Eq. 8). The total interaction energy (∆E) is the sum of the associated left hand bars. The separate sum of electrostatics and solvation is included to demonstrate the competition of these effects. The fragment exchange and correlation contributions to ∆E are largely determined by the fragment sizes and proximity to the protein. For example, the F3 fragment of the L8 system is shown to contribute −7.9 kcal/mol and −6.5 kcal/mol stability to ∆E through exchange and correlation effects respectively. As we would expect, in the larger and more closely interacting F3 fragment of L7 exchange and correlation are also greater (−12.7 kcal/mol and −11.9 kcal/mol respectively).
Overall, the full ligand contributions of exchange and correlation (up to −50.7 kcal/mol and −54.6 kcal/mol respectively) are comparable to the contributions of polarisation (up to −55.0 kcal/mol) and charge transfer (up to −50.0 kcal/mol). These effects therefore contribute important driving forces to binding. The fragmentation errors associated with exchange are consistently positive (3.1 kcal/mol to 3.5 kcal/mol), indicating that the fragment contributions slightly overestimate the stabilisation provided through exchange. This error is moderate when considering that this represents a 6.5-8.8% exchange contribution unattributable to any particular fragment.
An important aspect of the EDA is its ability to highlight potential drug modification regions that would induce stronger protein interaction. For example, in the F1 fragment interaction of L8
and L9 discussed earlier the benzene provides stability to the salt bridge interaction through resonance effects involving the amidine group. Here, the EDA might be used to evaluate placement of a functional group such as a halide to the benzene ring to both stabilise this interaction further and offer enhancement of electrostatic effects. Additionally, the EDA may support modification of the ligand F2 fragments due to their consistently repulsive frozen density component. Specifically, the electrostatic interactions of the F2 fragments are observed to be relatively small (−11.4 kcal/mol to −28.4 kcal/mol) when compared to the electrostatic interactions of the remaining fragments. Substitutions of these fragments tailored towards enhancing electrostatics may therefore be desired to attempt to increase the overall ligand binding enthalpy.
Polarisation and charge transfer
Here we consider the polarisation and charge transfer EDA components for the fragmented systems through their energy values and the EDD and ∆EDD plots shown in Figure 11 and Figure 12 .
The L8 and L9 ligands are observed to largely contribute to polarisation and charge transfer through their F1 fragments. These fragments show a similar total polarisation and charge transfer (∆E POL + ∆E CT ) contribution of −61.8 kcal/mol and −61.9 kcal/mol respectively. This strong interaction is due to the salt bridge interaction with Asp189, with contributions also observed from Gly219 and Cys220 and the water molecule in this pocket. As shown in Figure 11 The overall interaction of the protein with the L7 F2 fragment is moderately strong and likely stabilised greatly by this specific interaction: polarisation is −4.5 kcal/mol and charge transfer is −11.9 kcal/mol. This interaction is shown for L7 in Figure 11 (a) and Figure 12 (a).
In the L7 and L8 F3 fragments, stabilising contributions are also seen to arise through interaction of the ligands' charged amine groups with the Gly216 oxygen that result in formation of a δ + NH···OC bond (Figure 11 (a)-(c) and Figure 12(a)-(c) ). In the case of L9, the F3 fragment has a lesser interaction with the Gly216 oxygen atom due to the fact that this fragment is uncharged.
However, this fragment is more extended than the F3 fragments of L7 and L8 and as a result is able to interact with a larger area of the cavity surface. The overall weaker stabilisation provided by these interactions is reflected by a > 10 kcal/mol decrease in polarisation compared to the F3 fragments of L7 and L8, and a > 3 kcal/mol decrease in charge transfer.
Notably, the fragmentation error for the polarisation component of the L8 system is observed to be relatively high. This error is −9.9 kcal/mol, and therefore 18% of the polarisation is not attributable to any particular fragment. This is possibly the result of the fragmentation scheme we have adopted for this system, as the partitioned bonds will be unable to reproduce the polarisation effects seen in the full ligand. Related to this idea, it is possible that giving the F3 fragment of L8 a +1 integer charge is physically unjustifiable. This may be the case as this fragment is relatively small and may stabilise its electron deficiency by withdrawing charge from its neighbouring fragment (F2). This is evidenced by population analysis of the full ligand (performed at the same level of theory as the EDA) in which the fragment is observed to have a net charge of +0.91e (Mulliken population) and +0.89e (natural population), different to a +1 integer charge. This observation shows that care must be taken when partitioning bonds, especially in the case of small, charged fragments which should ideally be avoided.
Solvation
As we may expect for the ligands studied, solvation effects are seen to make substantial contributions to the binding energy of the ligands. By decomposing the solvation correction into different contributing regions of the ligand, we are able to gain insight into the effects of functional groups on this energy component. As discussed earlier, for charged fragments and ligands the electrostatic component is negatively correlated with the solvation energy. This is due to fact that elec-trostatically driven binding to the protein is associated with an electrostatic energy cost of solvent bond breaking to leave the solvent environment. For example, solvent effects for the charged F1 fragments of L8 (95.2 kcal/mol) and L9 (102.7 kcal/mol) mediate the strongly stabilising electrostatic interactions of these fragments with the protein (−129.2 kcal/mol and −135.7 kcal/mol respectively). Including the solvation effects in our description of the interaction energy ∆E, we see that overall the interactions are dominated by the salt bridge formation. This interaction involves the amidine groups contained in the F1 fragments of L8 (∆E = −21.4 kcal/mol) and L9
(∆E = −21.6 kcal/mol).
Conclusions
In this work, we have presented an application of the ONETEP energy decomposition analysis (EDA) to a series of binders interacting with the thrombin protein. Investigations of biomolecular interactions using EDA in the literature have often been limited to smaller model system studies and without seeking to visually analyse the specific structural regions involved in the interactions. 38, 50, 51 Here, we have shown the potential for EDA to aid in drug design through use of the energy components in combination with electron density difference (EDD) and ∆EDD plots for visualising the interactions. We note that the visualisation of electron redistributions through such plots is not directly possible using molecular mechanics-based approaches. This work applying EDA to protein-ligand systems greater than 2740 atoms in size therefore exemplifies the strength of large-scale quantum approaches for drug design. 52, 53 We have used the EDA to highlight a number of important interactions during thrombin binding. Specifically, we considered the interactions of a series of small S1 pocket fragments and larger drug-sized ligands with the binding cavity. A partitioning protocol for the ligands was introduced that enabled their interactions to be decomposed into their structural origins. This protocol was a simple yet robust procedure which we showed to maintain a high degree of chemical accuracy.
Our analysis evidenced the importance of the salt bridge interaction with the charged amidine group of the ligands, and highlighted the Asp189, Glu192, Ser195, Gly219 and Gly216 amino acid residues as playing important roles in thrombin binding through polarisation and charge transfer effects. The conformation of the highly flexible Glu192 was shown to be a significant factor for differences in the interactions of structurally comparable ligands such as the L5 and L6 ligand pair and the L8 and L9 ligand pair.
This work demonstrates the application of a whole new capability to a real protein drug target where accurate DFT calculations can produce both energetic and visual descriptors of interactions.
These descriptors can be used to provide insights for tailoring interactions, as needed for example in drug design. 
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